Literature DB >> 19631748

The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus.

Gyung W Kim1, Hyun-Jeong Kim, Kyoung-Joo Cho, Hyun-Woo Kim, Yang-Je Cho, Byung I Lee.   

Abstract

Recent studies demonstrate that matrix metalloproteinase-9 (MMP-9) is closely involved in the pathogenesis of epilepsy. This study investigated the role of MMP-9 in hippocampal cell death after pilocarpine-induced status epilepticus (SE). We showed that MMP-9 expression and activity significantly increased and beta1-integrin levels decreased on day 3 after SE. beta1-integrin degradation was also observed in hippocampal ex vivo extracts incubated with recombinant active MMP-9. Treatment with a selective MMP-9 inhibitor attenuated MMP-9 up-regulation, beta1-integrin degradation, the reduction of ILK activity and Akt phosphorylation, and subsequent hippocampal damage after SE. However, co-treatment with anti-beta1-integrin antibody almost completely blocked the protective effects of the MMP-9 inhibitor on both integrin-mediated survival signaling and hippocampal cell death. Our study demonstrates that MMP-9 induces apoptotic hippocampal cell death by interrupting integrin-mediated survival signaling after SE and suggests that MMP-9 may be a promising target for a neuroprotective approach to preventing seizure-induced hippocampal damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631748     DOI: 10.1016/j.nbd.2009.07.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  23 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

Review 2.  Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Authors:  Ralf G Rempe; Anika M S Hartz; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

3.  Matrix Metalloproteinase-9 Regulates Neuronal Circuit Development and Excitability.

Authors:  Sachiko Murase; Crystal L Lantz; Eunyoung Kim; Nitin Gupta; Richard Higgins; Mark Stopfer; Dax A Hoffman; Elizabeth M Quinlan
Journal:  Mol Neurobiol       Date:  2015-06-21       Impact factor: 5.590

4.  Minocycline reduces oxygen-glucose deprivation-induced PC12 cell cytotoxicity via matrix metalloproteinase-9, integrin β1 and phosphorylated Akt modulation.

Authors:  Xiaohong Chen; Shaoqiong Chen; Ying Jiang; Cansheng Zhu; Aimin Wu; Xiaomeng Ma; Fuhua Peng; Lili Ma; Dongliang Zhu; Qing Wang; Rongbiao Pi
Journal:  Neurol Sci       Date:  2012-12-07       Impact factor: 3.307

5.  Effects of Luteolin on Liver, Kidney and Brain in Pentylentetrazol-Induced Seizures: Involvement of Metalloproteinases and NOS Activities.

Authors:  Hüsniye Birman; Kadriye Akgün Dar; Ayşegül Kapucu; Samet Acar; Gülay Uzüm
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

6.  The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.

Authors:  Diede Wm Broekaart; Alexandra Bertran; Shaobo Jia; Anatoly Korotkov; Oleg Senkov; Anika Bongaarts; James D Mills; Jasper J Anink; Jesús Seco; Johannes C Baayen; Sander Idema; Elodie Chabrol; Albert J Becker; Wytse J Wadman; Teresa Tarragó; Jan A Gorter; Eleonora Aronica; Roger Prades; Alexander Dityatev; Erwin A van Vliet
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

7.  Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways.

Authors:  Hantamalala Ralay Ranaivo; Jessica N Hodge; Nicole Choi; Mark S Wainwright
Journal:  J Neuroinflammation       Date:  2012-04-16       Impact factor: 8.322

8.  Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer's disease, and epilepsy.

Authors:  Hiroyuki Mizoguchi; Kiyofumi Yamada; Toshitaka Nabeshima
Journal:  Biochem Res Int       Date:  2011-12-26

Review 9.  Roles of matrix metalloproteinases and their targets in epileptogenesis and seizures.

Authors:  Hiroyuki Mizoguchi; Kiyofumi Yamada
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-08-26       Impact factor: 2.582

10.  Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels.

Authors:  Ya-Jun Li; Zheng-Hai Wang; Bei Zhang; Xiao Zhe; Ming-Jue Wang; Shao-Ting Shi; Jing Bai; Tao Lin; Chang-Jiang Guo; Shi-Jun Zhang; Xiang-Li Kong; Xing Zuo; Hang Zhao
Journal:  J Neuroinflammation       Date:  2013-07-05       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.